CREFX
Price
$19.69
Change
+$0.20 (+1.03%)
Updated
Jul 2 closing price
Net Assets
9.36B
VRREX
Price
$20.97
Change
+$0.26 (+1.26%)
Updated
Jul 2 closing price
Net Assets
365M
Interact to see
Advertisement

CREFX vs VRREX

CREFX vs VRREX Comparison Chart in %
View a ticker or compare two or three
VS
CREFX vs. VRREX commentary
Jul 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CREFX is a Hold and VRREX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CREFX has more cash in the bank: 9.36B vs. VRREX (365M). CREFX pays higher dividends than VRREX: CREFX (2.76) vs VRREX (2.25). CREFX was incepted earlier than VRREX: CREFX (9 years) vs VRREX (12 years). VRREX (0.95) is less costly to investors than CREFX (0.75). CREFX is a more actively managed with annual turnover of: 27.00 vs. VRREX (17.00). CREFX has a lower initial minimum investment than VRREX: CREFX (0) vs VRREX (2500000). VRREX annual gain was more profitable for investors over the last year : 15.25 vs. CREFX (13.69). CREFX return over 5 years is better than : 15.57 vs. VRREX (-4.79).
CREFXVRREXCREFX / VRREX
Total Expense Ratio0.750.7995%
Annual Report Gross Expense Ratio0.750.9579%
Fund Existence9 years12 years-
Gain YTD14.96819.03579%
Front LoadN/AN/A-
Min. Initial Investment02500000-
Min. Initial Investment IRAN/AN/A-
Net Assets9.36B365M2,564%
Annual Yield % from dividends2.762.25123%
Returns for 1 year13.6915.2590%
Returns for 3 years35.1215.14232%
Returns for 5 years15.57-4.79-325%
Returns for 10 yearsN/A-30.89-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GPGEX10.480.10
+0.96%
Grandeur Peak Global Explorer Instl
JAAGX84.18-0.02
-0.02%
Janus Henderson VIT Enterprise Instl
FEYAX33.72-0.04
-0.12%
Fidelity Advisor Asset Manager 85% A
IVPSX15.51-0.13
-0.83%
Voya Small Company Port S
BRWSX28.64-0.31
-1.07%
MFS Blended Research Growth Eq R2